Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
出版年份 2019 全文链接
标题
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
作者
关键词
Tuberculosis, Health care policy, Clinical trials, Drug research and development, Drug policy, Drug therapy, Public and occupational health, Science policy
出版物
PLOS MEDICINE
Volume 16, Issue 9, Pages e1002915
出版商
Public Library of Science (PLoS)
发表日期
2019-09-07
DOI
10.1371/journal.pmed.1002915
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
- (2019) Patrick P. J. Phillips et al. PLOS MEDICINE
- Advances in clinical trial design for development of new TB treatments: A call for innovation
- (2019) Christian Lienhardt et al. PLOS MEDICINE
- Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs
- (2019) Geraint Davies et al. PLOS MEDICINE
- The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis
- (2018) Elin M Svensson et al. CLINICAL INFECTIOUS DISEASES
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
- (2018) Simon Tiberi et al. LANCET INFECTIOUS DISEASES
- Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
- (2018) Nafees Ahmad et al. LANCET
- Bacterial Factors That Predict Relapse after Tuberculosis Therapy
- (2018) Roberto Colangeli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Target regimen profiles for treatment of tuberculosis: a WHO document
- (2017) Christian Lienhardt et al. EUROPEAN RESPIRATORY JOURNAL
- Challenges in the Design and Interpretation of Noninferiority Trials
- (2017) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
- (2016) Patrick P. J. Phillips et al. BMC Medicine
- Assessment of treatment response in tuberculosis
- (2016) Neesha Rockwood et al. Expert Review of Respiratory Medicine
- Adaptive clinical trials in tuberculosis: applications, challenges and solutions
- (2015) G. R. Davies et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap
- (2011) Payam Nahid et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Biomarkers for tuberculosis disease activity, cure, and relapse
- (2010) Patrick Peter John Phillips et al. LANCET INFECTIOUS DISEASES
- Going from evidence to recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started